Evolution of Ulcerative Colitis Outcomes: Moving Beyond Endoscopic Remission Toward Histologic Endoscopic Mucosal Improvement

This Special Report outlines considerations in assessing mucosal healing as part of the standard of care for ...

OCTOBER 12, 2022

Normalization of Fecal Calprotectin A Proxy Target in Crohn’s

Achievement of a normal level of fecal calprotectin within a year of diagnosis of Crohn’s disease is ...

NOVEMBER 6, 2020

New Validation for Treat-to-Target Approach In UC From Phase 3 Data

For patients with ulcerative colitis, new evidence indicates that deeper response at induction of biologic therapy, ...

FEBRUARY 24, 2020

New ‘Natural’ Options Available for Enteral Nutrition

Enteral nutrition plays an important role in the management of people with inflammatory bowel disease, helping to ...

JANUARY 24, 2020

Histologic Activity Predicts Relapse in Ileal Crohn’s

Deeper remission provides better outcomes for patients with ileal Crohn’s disease, according to a new study ...

DECEMBER 6, 2018

Novel ‘DNAzyme’ Improves Outcomes In Ulcerative Colitis

Blocking the GATA-3 pathway to inhibit the downstream release of cytokines resulted in clinical response and ...

NOVEMBER 7, 2018

Symptoms of UC Adequate Gauge of Mucosal Healing

For evaluation of mucosal healing in patients with ulcerative colitis, clinical assessment and endoscopy findings ...

JUNE 11, 2018

Blood Test for Mucosal Healing May Facilitate Management of Crohn’s Disease

A panel of biomarkers in blood can detect mucosal healing in patients with Crohn’s disease, according to a ...

JANUARY 16, 2018